In addition, GSE can downregulate urokinase plasminogen activator (uPA) and DNA-binding activity of the transcription factor nuclear factor kappa B (NF-κB) in highly metastatic androgen-independent PC3 prostate cancer cells and therefore inhibits cell invasion [75]. Here, PLAU is linked to prostate cancer.